Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

If insulin delivery is stopped unexpectedly, hyperglycemia or diabetic ketoacidosis could result. Users are advised to replace the battery as soon as the "low battery pump" alarm sounds. Medtronic ...

If you have type 1 diabetes and are on multiple daily injections, you may be eligible to join a trial studying the use of a new overnight patch pump. This virtual, at-home clinical trial will be ...

As a specialist Online Grundfos Distributor®, the team at Online Pump Supplies are experts in the high quality range from the industry leading manufacturer. Grundfos is one of - if not the - leading ...

Diabetes afflicts more than half a billion people worldwide, and causes nearly seven million deaths a year. In recent decades, the prevalence of this disease characterised by elevated levels of blood ...

Border Free Health offers a wide range of diabetic supplies, including insulin pumps, blood glucose meters, and continuous glucose monitoring devices, at prices up to 80% off retail. The company ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because ... potentially leading to diabetic ketoacidosis ...

WARSAW — Medtronic is notifying users of MiniMed 600 and 700 series insulin pumps of an increased risk for reduced battery life and less time until shutdown after a battery alert occurs. Pumps that ...

Opens in a new tab or window A shorter-than-expected battery life prompted a voluntary recall of certain insulin pumps from Medtronic's MiniMed 600 and 700 series, the FDA detailed on Thursday.

Caring for your health after a diabetes ... the pump,” the Safety Alert states. “Please note that even a single drop could result in reduced battery life, either immediately after the drop, or over ...

A new treatment combining ReCET and semaglutide eliminated insulin use in 86% of type 2 diabetes patients, improving natural insulin sensitivity. A new treatment combining ReCET and semaglutide could ...